您的位置: 首页 > 农业专利 > 详情页

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER
专利权人:
INC.;PRIMEVAX IMMUNO-ONCOLOGY
发明人:
Bruce W. LYDAY
申请号:
US16413444
公开号:
US20190298764A1
申请日:
2019.05.15
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Described herein are compositions and methods for treating a disease, particularly a cancer, with an immune checkpoint modulatory agent and a strain of an Arbovirus or a strain of an Alphavirus. Also provided herein are also methods for combination therapy comprising administration of an immune checkpoint modulatory agent, tumor antigen primed dendritic cells and an Alphavirus or an Arbovirus.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充